Free Trial

Kinaxis (TSE:KXS) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Kinaxis logo with Computer and Technology background

Key Points

  • Stifel Nicolaus raised its price target for Kinaxis (TSE:KXS) from C$225.00 to C$245.00, suggesting an 18.16% potential upside from its current price.
  • Recent reports show mixed analyst ratings, with two recommending a hold and four issuing a buy rating, indicating a consensus rating of "Moderate Buy" and an average target price of C$207.86.
  • Insider trading activity indicates significant sales, with insiders collectively selling 77,493 shares worth over $15 million in the last quarter.
  • Five stocks we like better than Kinaxis.

Kinaxis (TSE:KXS - Get Free Report) had its price target upped by stock analysts at Stifel Nicolaus from C$225.00 to C$245.00 in a research note issued to investors on Thursday,BayStreet.CA reports. The brokerage currently has a "buy" rating on the stock. Stifel Nicolaus' price objective indicates a potential upside of 18.16% from the stock's current price.

Other equities analysts also recently issued reports about the company. ATB Capital downgraded Kinaxis from an "outperform" rating to a "sector perform" rating and set a C$210.00 price objective on the stock. in a report on Friday, May 9th. Royal Bank Of Canada raised their price objective on Kinaxis from C$210.00 to C$225.00 in a report on Friday, May 9th. Atb Cap Markets downgraded Kinaxis from a "strong-buy" rating to a "hold" rating in a report on Thursday, May 8th. Finally, BMO Capital Markets raised their target price on Kinaxis from C$190.00 to C$225.00 in a report on Friday, May 9th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, Kinaxis presently has a consensus rating of "Moderate Buy" and an average target price of C$207.86.

Get Our Latest Stock Analysis on KXS

Kinaxis Price Performance

TSE:KXS traded up C$2.32 during trading hours on Thursday, hitting C$207.35. The company's stock had a trading volume of 19,616 shares, compared to its average volume of 76,969. The company has a debt-to-equity ratio of 12.12, a quick ratio of 2.29 and a current ratio of 1.89. The company has a market capitalization of C$4.17 billion, a PE ratio of 205.79, a PEG ratio of 3.60 and a beta of 0.78. Kinaxis has a 52-week low of C$132.93 and a 52-week high of C$212.45. The business's 50-day moving average is C$200.16 and its two-hundred day moving average is C$180.67.

Insider Buying and Selling

In other news, Director Robert G. Courteau sold 4,662 shares of the business's stock in a transaction on Monday, May 12th. The stock was sold at an average price of C$194.79, for a total value of C$908,103.52. Also, Senior Officer Mark Justin Morgan sold 7,397 shares of the business's stock in a transaction on Monday, May 12th. The stock was sold at an average price of C$194.79, for a total value of C$1,440,849.79. In the last quarter, insiders have sold 77,493 shares of company stock worth $15,063,388. 1.20% of the stock is currently owned by insiders.

Kinaxis Company Profile

(Get Free Report)

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines